Corey Pelletier

1.2k total citations
76 papers, 841 citations indexed

About

Corey Pelletier is a scholar working on Oncology, Economics and Econometrics and Surgery. According to data from OpenAlex, Corey Pelletier has authored 76 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 18 papers in Economics and Econometrics and 11 papers in Surgery. Recurrent topics in Corey Pelletier's work include Health Systems, Economic Evaluations, Quality of Life (11 papers), Thyroid Cancer Diagnosis and Treatment (9 papers) and Helicobacter pylori-related gastroenterology studies (8 papers). Corey Pelletier is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (11 papers), Thyroid Cancer Diagnosis and Treatment (9 papers) and Helicobacter pylori-related gastroenterology studies (8 papers). Corey Pelletier collaborates with scholars based in United States, United Kingdom and Japan. Corey Pelletier's co-authors include Jason D. Weber, David H. Gutmann, Danielle K. Sandsmark, Monika Parisi, Matthew Magestro, François Maltais, Y. Lacasse, Manish Patel, R. Bégin and Machaon Bonafede and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Corey Pelletier

73 papers receiving 828 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Corey Pelletier United States 17 259 235 184 163 103 76 841
Kazuhiko Fujii Japan 17 238 0.9× 365 1.6× 195 1.1× 230 1.4× 126 1.2× 63 921
Radosław Mlak Poland 17 250 1.0× 286 1.2× 285 1.5× 210 1.3× 96 0.9× 109 892
Seth Porter United States 11 125 0.5× 287 1.2× 235 1.3× 108 0.7× 46 0.4× 21 799
Brent Shoji United States 8 355 1.4× 226 1.0× 172 0.9× 91 0.6× 233 2.3× 8 807
A.R. Abdul Razak Canada 11 435 1.7× 283 1.2× 211 1.1× 79 0.5× 64 0.6× 26 760
Seung‐Hoon Beom South Korea 17 459 1.8× 361 1.5× 150 0.8× 77 0.5× 230 2.2× 69 901
Roeliene C. Kruizinga Netherlands 13 555 2.1× 111 0.5× 253 1.4× 193 1.2× 92 0.9× 14 1.1k
Christian Kersten Norway 21 745 2.9× 210 0.9× 330 1.8× 170 1.0× 195 1.9× 68 1.3k
Hani Rayess United States 12 156 0.6× 101 0.4× 328 1.8× 186 1.1× 234 2.3× 26 948

Countries citing papers authored by Corey Pelletier

Since Specialization
Citations

This map shows the geographic impact of Corey Pelletier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corey Pelletier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corey Pelletier more than expected).

Fields of papers citing papers by Corey Pelletier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corey Pelletier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corey Pelletier. The network helps show where Corey Pelletier may publish in the future.

Co-authorship network of co-authors of Corey Pelletier

This figure shows the co-authorship network connecting the top 25 collaborators of Corey Pelletier. A scholar is included among the top collaborators of Corey Pelletier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corey Pelletier. Corey Pelletier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hudgens, Stacie, et al.. (2023). Development and validation of a psoriasis treatment acceptability measure through group concept mapping. Health and Quality of Life Outcomes. 21(1). 83–83. 1 indexed citations
2.
Vaezi, Michael F., Stephen Brunton, A. Mark Fendrick, et al.. (2022). Patient journey in erosive oesophagitis: real-world perspectives from US physicians and patients. BMJ Open Gastroenterology. 9(1). e000941–e000941. 2 indexed citations
3.
Malfertheiner, Peter, Steven F. Moss, Patrick Daniele, et al.. (2022). Potassium-Competitive Acid Blocker and Proton Pump Inhibitor–Based Regimens for First-Line Helicobacter pylori Eradication: A Network Meta-Analysis. SHILAP Revista de lepidopterología. 1(5). 824–834. 14 indexed citations
4.
Howden, Colin W., Stuart J. Spechler, Michael F. Vaezi, et al.. (2022). Study of Acid-related Disorders: Real-world Physician and Patient Perspectives on Burden of Helicobacter pylori Infection. SHILAP Revista de lepidopterología. 1(2). 231–240. 3 indexed citations
5.
Pelletier, Corey, et al.. (2020). Switch Rates and Total Cost of Care Associated with Apremilast and Biologic Therapies in Biologic-Naive Patients with Plaque Psoriasis. SHILAP Revista de lepidopterología. 1 indexed citations
6.
Wu, Jashin J., et al.. (2020). Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis. Advances in Therapy. 37(5). 2098–2115. 8 indexed citations
7.
Bonafede, Machaon, et al.. (2020). PND19 PRODUCTIVITY LOSS AMONG CAREGIVERS OF PATIENTS WITH MS. Value in Health. 23. S261–S262. 1 indexed citations
8.
Kaplan, David L., et al.. (2020). <p>Switch Rates and Total Cost of Care Associated with Apremilast and Biologic Therapies in Biologic-Naive Patients with Plaque Psoriasis</p>. ClinicoEconomics and Outcomes Research. Volume 12. 369–377. 9 indexed citations
9.
Parisi, Monika, Stefan Glück, Sungha Park, et al.. (2018). Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis. SHILAP Revista de lepidopterología. 2 indexed citations
10.
Cartwright, Thomas H., Monika Parisi, Janet L. Espirito, et al.. (2018). Clinical Outcomes with First-Line Chemotherapy in a Large Retrospective Study of Patients with Metastatic Pancreatic Cancer Treated in a US Community Oncology Setting. Drugs - Real World Outcomes. 5(3). 149–159. 33 indexed citations
11.
Patel, Manali I., Monika Parisi, Corey Pelletier, Charles Bennett, & Peter Georgantopoulos. (2017). P1.06-020 Prevalence of Autoimmune Disease in US Veterans With Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 12(1). S677–S678. 3 indexed citations
12.
13.
14.
Tremblay, Gabriel, et al.. (2016). Cost-Effectiveness Analysis of Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in the United States. Value in Health. 19(3). A151–A151. 4 indexed citations
15.
16.
17.
Tremblay, Gabriel, Tim Holbrook, Gary Milligan, & Corey Pelletier. (2015). Matching-Adjusted Indirec Treatment Comparison And Survival Extrapolation In Radioiodine-Refractory Differentiated Thyroid Cancer (Rai-Refractory Dtc). Value in Health. 18(3). A11–A11. 1 indexed citations
18.
Eijkemans, Marinus J.C., Kit C. B. Roes, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, et al.. (2015). Long-term Follow-up Assessing Renal Angiomyolipoma Treatment Patterns, Morbidity, and Mortality: An Observational Study in Tuberous Sclerosis Complex Patients in the Netherlands. American Journal of Kidney Diseases. 66(4). 638–645. 89 indexed citations
19.
Maggi, Leonard B., et al.. (2009). Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation. Oncogene. 28(36). 3209–3220. 19 indexed citations
20.
Sandsmark, Danielle K., et al.. (2007). Nucleophosmin Mediates Mammalian Target of Rapamycin–Dependent Actin Cytoskeleton Dynamics and Proliferation in Neurofibromin-Deficient Astrocytes. Cancer Research. 67(10). 4790–4799. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuhiko Fujii Breakdown of academic impact, for papers by Radosław Mlak Breakdown of academic impact, for papers by Seth Porter Breakdown of academic impact, for papers by Brent Shoji Breakdown of academic impact, for papers by A.R. Abdul Razak Breakdown of academic impact, for papers by Seung‐Hoon Beom Breakdown of academic impact, for papers by Roeliene C. Kruizinga Breakdown of academic impact, for papers by Christian Kersten Breakdown of academic impact, for papers by Hani Rayess
Rankless by CCL
2026